Skip Navigation



Annals of Oncology Advance Access published online on February 16, 2005
Annals of Oncology, doi:10.1093/annonc/mdi101
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/4/673    most recent
mdi101v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Pas, T.
Right arrow Articles by de Braud, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Pas, T.
Right arrow Articles by de Braud, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter

Reply to the article "Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity" by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543-1550): ... and in humans?

T. De Pas 1*, M. Colleoni 1, L. Orlando 1, G. Masci 1, A. Rocca 1, C. Catania 1, G. Curigliano 1, S. Manzoni 1, A. Goldhirsch 1, and F. de Braud 1

1 Department of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy

* To whom correspondence should be addressed.
T. De Pas, E-mail: tommaso.de-pas{at}ieo.it



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.